Expression and evaluation of porcine circovirus type 2 capsid protein mediated by recombinant adeno-associated virus 8

다국어 초록 (Multilingual Abstract)

Background: Porcine circovirus type 2 (PCV2) is an important infectious pathogen implicated in porcine circovirus-associated diseases (PCVAD), which has caused significant economic losses in the pig industry worldwide.
Objectives: A suitable viral vector-mediated gene transfer platform for the expression of the capsid protein (Cap) is an attractive strategy.
Methods: In the present study, a recombinant adeno-associated virus 8 (rAAV8) vector was constructed to encode Cap (Cap-rAAV) in vitro and in vivo after gene transfer.
Results: The obtained results showed that Cap could be expressed in HEK293T cells and BABL/c mice. The results of lymphocytes proliferative, as well as immunoglobulin G (IgG) 2a and interferon-γ showed strong cellular immune responses induced by Cap-rAAV. The enzyme-linked immunosorbent assay titers obtained and the IgG1 and interleukin-4 levels showed that humoral immune responses were also induced by Cap-rAAV. Altogether, these results demonstrated that the rAAV8 vaccine Cap-rAAV can induce strong cellular and humoral immune responses, indicating a potential rAAV8 vaccine against PCV2.
Conclusions: The injection of rAAV8 encoding PCV2 Cap genes into muscle tissue can ensure long-term, continuous, and systemic expression.

참고문헌 (Reference)

1 Seder RA, "Vaccines against intracellular infections requiring cellular immunity" 406 (406): 793-798, 2000

2 Qiu-Hua Wang, "The effect of Panax notoginseng saponins on oxidative stress induced by PCV2 infection in immune cells: in vitro and in vivo studies" 대한수의학회 21 (21): 0-0, 2020

3 Mendell JR, "Single-dose genereplacement therapy for spinal muscular atrophy" 377 (377): 1713-1722, 2017

4 Shen HG, "Protective immunity against porcine circovirus 2by vaccination with ORF2-based DNA and subunit vaccines in mice" 89 (89): 1857-1865, 2008

5 Karuppannan AK, "Porcine circovirus type 2(PCV2)vaccines in the context of current molecular epidemiology" 9 (9): 99-, 2017

6 Wang T, "Porcine MKRN1 modulates the replication and pathogenesis of porcine circovirus type 2 by inducing capsid protein ubiquitination and degradation" 92 (92): e00100-e00118, 2018

7 Eclercy J, "PCV2 co-infection does not impact PRRSV MLV1 safety but enhances virulence of a PRRSV MLV1-like strain in infected SPF pigs" 244 : 108656-, 2020

8 Wang L, "Oral vaccination with the porcine circovirus type 2(PCV-2)capsid protein expressed by Lactococcus lactis induces a specific immune response against PCV-2 in mice" 128 (128): 74-87, 2020

9 Huang L, "Neutralization mechanism of a monoclonal antibody targeting a porcine circovirus type 2 Cap protein conformational epitope" 94 (94): e01836-e01819, 2020

10 Giles AR, "Mapping an adeno-associated virus 9-specific neutralizing epitope to develop next-generation gene delivery vectors" 92 (92): e01011-e01018, 2018

11 Bryant LM, "Lessons learned from the clinical development and market authorization of Glybera" 24 (24): 55-64, 2013

12 Wang X, "Ivermectin treatment inhibits the replication of porcine circovirus 2(PCV2)in vitro and mitigates the impact of viral infection in piglets" 263 : 80-86, 2019

13 Shen HG, "Interference of porcine circovirus type 2 ORF2immunogenicity by ORF1 and ORF3 mixed DNA immunizations in mice" 393 (393): 104-111, 2009

14 Li D, "Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs" 35 (35): 4722-4729, 2017

15 Smalley E, "First AAV gene therapy poised for landmark approval" 35 (35): 998-999, 2017

16 Yu Y, "Expression of HIV-1 broadly neutralizing antibodies mediated by recombinant adeno-associated virus 8 in vitro and in vivo" 80 : 68-77, 2016

17 Zhencang Zhang, "Enhanced protective immune response to PCV2 adenovirus vaccine by fusion expression of Cap protein with InvC in pigs" 대한수의학회 20 (20): 1-12, 2019

18 Wei C, "Emergence of a novel recombinant porcine circovirus type 2 in China : PCV2c and PCV2d recombinant" 66 (66): 2496-2506, 2019

19 Duan J, "Efficient production of porcine circovirus virus-like particles using the nonconventional yeast Kluyveromyces marxianus" 103 (103): 833-842, 2019

20 김혜권, "Duplex nested reverse transcriptase polymerase chain reaction for simultaneous detection of type 2 porcine reproductive and respiratory syndrome virus and porcine circovirus type 2 from tissue samples" 대한수의학회 18 (18): 253-256, 2017

21 Cao W, "Development of a simple and high-yielding fed-batch process for the production of porcine circovirus type 2 virus-like particle subunit vaccine" 9 (9): 164-, 2019

22 Segalés J, "Best practice and future challenges for vaccination against porcine circovirus type 2" 14 (14): 473-487, 2015

23 신민경, "Assessing PCV2 antibodies in field pigs vaccinated with different porcine circovirus 2 vaccines using two commercial ELISA systems" 대한수의학회 16 (16): 25-29, 2015

24 Penaud-Budloo M, "Adenoassociated virus vector genomes persist as episomal chromatin in primate muscle" 82 (82): 7875-7885, 2008

25 Huang L, "A broad spectrum monoclonal antibody against porcine circovirus type 2 for antigen and antibody detection" 103 (103): 3453-3464, 2019